|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/10 | (2006.01) |
| A61P 11/00 | (2006.01) | ||
| A61K 31/40 | (2006.01) | ||
| A61K 31/519 | (2006.01) | ||
| A61K 47/14 | (2017.01) |
| (11) | Number of the document | 4110292 |
| (13) | Kind of document | T |
| (96) | European patent application number | 21709782.3 |
| Date of filing the European patent application | 2021-02-26 | |
| (97) | Date of publication of the European application | 2023-01-04 |
| (45) | Date of publication and mention of the grant of the patent | 2024-01-10 |
| (46) | Date of publication of the claims translation | 2024-02-12 |
| (86) | Number | PCT/GB2021/050496 |
| Date | 2021-02-26 |
| (87) | Number | WO 2021/171034 |
| Date | 2021-09-02 |
| (30) | Number | Date | Country code |
| 202002786 | 2020-02-27 | GB |
| (72) |
SPARGO, Peter Lionel , GB
HAYWOOD, Phillip Andrew , GB
FRENCH, Edward James , GB
|
| (73) |
Verona Pharma PLC ,
One Central Square, Cardiff
CF10 1FS,
GB
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Skysta farmacinė kompozicija, apimanti ensifentriną ir glikopirolatą |
| LIQUID PHARMACEUTICAL COMPOSITION COMPRISING ENSIFENTRINE AND GLYCOPYRROLATE |
| Payment date | Validity (years) | Amount | |
| 2025-01-20 | 5 | 115.00 EUR |
| 2026-02-26 |